Literature DB >> 2106753

Subclinical course of cholesterol ester storage disease (CESD) diagnosed in adulthood. Report on two cases with remarks on the nature of the liver storage process.

M Elleder1, J Ledvinová, P Cieslar, R Kuhn.   

Abstract

An extremely benign variant of cholesterol ester storage disease (CESD) was diagnosed in two female patients aged 43 and 56 years. In one of them the course was entirely subclinical until a stroke at the age of 47, most probably a complication of secondary hyperlipoproteinaemia. The diagnosis was made accidentally in vivo during extensive examination for concomitant monoclonal gammapathy. The other patient (aged 56), still displays a fairly stable course with minor dyspeptic symptoms. The clinical findings in both patients were confined to moderate well tolerated hepatomegaly, hyperlipoproteinaemia of IIb type and xanthelasmata. Acid lipase activity was markedly deficient in peripheral leukocytes and cultured fibroblasts. These cases represent a rare adult variant the existence of which should be borne in mind in the differential diagnosis of chronic liver disease in advanced age and of hyperlipoproteinaemic states. The diagnostic criteria for the routine clinicopathological steps are summarized with emphasis on a special lipopigment deposition pattern, encompassing inhibition and modification of lipofuscin generation in hepatocytes and an excess of ceroid production in both portal and intralobular histiocytes. The varied ultrastructural appearance of the lysosomal limiting membrane complex is described.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106753     DOI: 10.1007/bf01605297

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  21 in total

1.  Primary familial xanthomatosis with involvement and calcification of the adrenals. Report of two more cases in siblings of a previously described infant.

Authors:  M WOLMAN; V V STERK; S GATT; M FRENKEL
Journal:  Pediatrics       Date:  1961-11       Impact factor: 7.124

2.  [Unusual congenital cholesterol ester storage in the liver].

Authors:  H Wolf; G Hug; R Michaelis; K Nolte
Journal:  Helv Paediatr Acta       Date:  1974-06

3.  Unusual lysosomes in hamster hepatocytes.

Authors:  J L Nehemiah; A B Novikoff
Journal:  Exp Mol Pathol       Date:  1974-12       Impact factor: 3.362

4.  Acid lipase in cultured fibroblasts: cholesterol ester storage disease.

Authors:  A L Beaudet; M H Lipson; G D Ferry; B L Nichols
Journal:  J Lab Clin Med       Date:  1974-07

5.  [Cholesterolic polycoria in adults. I. Clinical and histochemical study].

Authors:  A Lageron; J Caroli; H Stralin; P Barbier
Journal:  Presse Med       Date:  1967-12-25       Impact factor: 1.228

6.  [Cholesterol ester storage disease (CESD)].

Authors:  J Hanák; M Elleder
Journal:  Cesk Pediatr       Date:  1984-12

7.  Cholesterol ester storage disease and mesenteric lipodystrophy.

Authors:  H P Dincsoy; D B Rolfes; C A McGraw; W K Schubert
Journal:  Am J Clin Pathol       Date:  1984-02       Impact factor: 2.493

8.  Cholesteryl ester storage disease and Wolman disease: phenotypic variants of lysosomal acid cholesteryl ester hydrolase deficiency.

Authors:  J M Hoeg; S J Demosky; O H Pescovitz; H B Brewer
Journal:  Am J Hum Genet       Date:  1984-11       Impact factor: 11.025

9.  Liver findings in Niemann-Pick disease type C.

Authors:  M Elleder; F Smíd; H Hyniová; J Cihula; J Zeman; M Macek
Journal:  Histochem J       Date:  1984-11

10.  Lysosomal non-lipid component of Gaucher's cells.

Authors:  M Elleder; F Smíd
Journal:  Virchows Arch B Cell Pathol       Date:  1977-12-30
View more
  4 in total

Review 1.  Cholesterol ester storage disease (CESD) diagnosed in an asymptomatic adult.

Authors:  Hemant Chatrath; Steven Keilin; Bashar M Attar
Journal:  Dig Dis Sci       Date:  2008-05-14       Impact factor: 3.199

2.  Orthotopic liver transplantation in an adult with cholesterol ester storage disease.

Authors:  Graeme K Ambler; Matthew Hoare; Rebecca Brais; Ashley Shaw; Andrew Butler; Paul Flynn; Patrick Deegan; William J H Griffiths
Journal:  JIMD Rep       Date:  2012-07-24

Review 3.  Novel treatment options for lysosomal acid lipase deficiency: critical appraisal of sebelipase alfa.

Authors:  Kim Su; Emma Donaldson; Reena Sharma
Journal:  Appl Clin Genet       Date:  2016-10-17

4.  Coronary Artery Disease-Associated LIPA Coding Variant rs1051338 Reduces Lysosomal Acid Lipase Levels and Activity in Lysosomes.

Authors:  Gavin E Morris; Peter S Braund; Jasbir S Moore; Nilesh J Samani; Veryan Codd; Tom R Webb
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-03-09       Impact factor: 8.311

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.